|
1
|
Mayr F and Heinemann U: Mechanisms of
Lin28-mediated miRNA and mRNA regulation-a structural and
functional perspective. Int J Mol Sci. 14:16532–16553. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Ratanasirintrawoot S,
Chandrasekaran S, Wu Z, Ficarro SB, Yu C, Ross CA, Cacchiarelli D,
Xia Q, Seligson M, et al: Lin28 regulates stem cell metabolism and
conversion to primed pluripotency. Cell Stem Cell. 19:66–80. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Z, Radaeva M, Cherkasov A and Dong X:
Lin28 regulates cancer cell stemness for tumour progression.
Cancers (Basel). 14:46402022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanna J, Saha K, Pando B, van Zon J,
Lengner CJ, Creyghton MP, van Oudenaarden A and Jaenisch R: Direct
cell reprogramming is a stochastic process amenable to
acceleration. Nature. 462:595–601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu J, Vodyanik MA, Smuga-Otto K,
Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA,
Ruotti V, Stewart R, et al: Induced pluripotent stem cell lines
derived from human somatic cells. Science. 318:1917–1920. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hamano R, Miyata H, Yamasaki M, Sugimura
K, Tanaka K, Kurokawa Y, Nakajima K, Takiguchi S, Fujiwara Y, Mori
M and Doki Y: High expression of Lin28 is associated with tumour
aggressiveness and poor prognosis of patients in oesophagus cancer.
Br J Cancer. 106:1415–1423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li M, Chen H and Wu T: LIN28: A cancer
stem cell promoter for immunotherapy in head and neck squamous cell
carcinoma. Oral Oncol. 98:92–95. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsialikas J and Romer-Seibert J: LIN28:
Roles and regulation in development and beyond. Development.
142:2397–2404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Balzeau J, Menezes MR, Cao S and Hagan JP:
The LIN28/let-7 pathway in cancer. Front Genet. 8:312017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piskounova E, Polytarchou C, Thornton JE,
LaPierre RJ, Pothoulakis C, Hagan JP, Iliopoulos D and Gregory RI:
Lin28A and Lin28B inhibit let-7 MicroRNA biogenesis by distinct
mechanisms. Cell. 147:1066–1079. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haq S, Das S, Kim DH, Chandrasekaran AP,
Hong SH, Kim KS and Ramakrishna S: The stability and oncogenic
function of LIN28A are regulated by USP28. Biochim Biophys Acta Mol
Basis Dis. 1865:599–610. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsanov KM, Pearson DS, Wu Z, Han A,
Triboulet R, Seligson MT, Powers JT, Osborne JK, Kane S, Gygi SP,
et al: LIN28 phosphorylation by MAPK/ERK couples signalling to the
post-transcriptional control of pluripotency. Nat Cell Biol.
19:60–67. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Xie C, Zheng X, Nie X, Wang Z, Liu
H and Zhao Y: LIN28/ let-7/PD-L1 pathway as a target for
cancer immunotherapy. Cancer Immunol Res. 7:487–497. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu J, Zhang Z, Huang L, Xiong J, Zhou Z,
Yu H, Wu L, Liu Z and Cao K: Let-7a suppresses Ewing sarcoma CSCs'
malignant phenotype via forming a positive feedback circuit with
STAT3 and lin28. J Bone Oncol. 31:1004062021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang R, Dong H, Jia S and Yang Z:
Resveratrol as a modulatory of apoptosis and autophagy in cancer
therapy. Clin Transl Oncol. 24:1219–1230. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SR, Jin H, Kim WT, Kim WJ, Kim SZ,
Leem SH and Kim SM: Tristetraprolin activation by resveratrol
inhibits the proliferation and metastasis of colorectal cancer
cells. Int J Oncol. 53:1269–1278. 2018.PubMed/NCBI
|
|
17
|
Sauter ER: Cancer prevention and treatment
using combination therapy with natural compounds. Expert Rev Clin
Pharmacol. 13:265–285. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu
W and Zheng Q: Natural products as anticancer agents: Current
status and future perspectives. Molecules. 27:83672022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Farooqi A, Khalid S and Ahmad A:
Regulation of cell signaling pathways and miRNAs by resveratrol in
different cancers. Int J Mol Sci. 19:6522018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren B, Kwah MXY, Liu C, Ma Z, Shanmugam
MK, Ding L, Xiang X, Ho PC, Wang L, Ong PS and Goh BC: Resveratrol
for cancer therapy: Challenges and future perspectives. Cancer
Lett. 515:63–72. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tykwinska K, Lauster R, Knaus P and
Rosowski M: Growth and differentiation factor 3 induces expression
of genes related to differentiation in a model of cancer stem cells
and protects them from retinoic acid-induced apoptosis. PLoS One.
8:e706122013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yun JH, Kim KA, Yoo G, Kim SY, Shin JM,
Kim JH, Jung SH, Kim J and Nho CW: Phenethyl isothiocyanate
suppresses cancer stem cell properties in vitro and in a xenograft
model. Phytomedicine. 30:42–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You JS, Kang JK, Seo DW, Park JH, Park JW,
Lee JC, Jeon YJ, Cho EJ and Han JW: Depletion of embryonic stem
cell signature by histone deacetylase inhibitor in NCCIT cells:
Involvement of nanog suppression. Cancer Res. 69:5716–5725. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jodynis-Liebert J and Kujawska M: Biphasic
dose-response induced by phytochemicals: Experimental evidence. J
Clin Med. 9:7182020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
You X, Liu F, Zhang T, Lv N, Liu Q, Shan
C, Du Y, Kong G, Wang T, Ye L and Zhang X: Hepatitis B virus X
protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the
proliferation of hepatoma cells. Oncogene. 33:449–460. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo L, Chen C, Shi M, Wang F, Chen X, Diao
D, Hu M, Yu M, Qian L and Guo N: Stat3-coordinated
Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain
oncostatin M-driven epithelial-mesenchymal transition. Oncogene.
32:5272–5282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhuo ZL, Xian HP, Sun YJ, Long Y, Liu C,
Liang B and Zhao XT: Long noncoding RNA ZNFX1-AS1 promotes the
invasion and proliferation of gastric cancer cells by regulating
LIN28 and CAPR1N1. World J Gastroenterol. 28:4973–4992. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi H, Xie J, Wang K, Li W, Yin L, Wang G,
Wu Z, Ni J, Mao W, Guo C and Peng B: LINC01451 drives
epithelial-mesenchymal transition and progression in bladder cancer
cells via LIN28/TGF-β/Smad pathway. Cell Signal. 81:1099322021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krsnik D, Marić T, Bulić-Jakuš F, Sinčić N
and Bojanac AK: LIN28 family in testis: Control of cell renewal,
maturation, fertility and aging. Int J Mol Sci. 23:72452022.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee S, Wottrich S and Bonavida B:
Crosstalks between Raf-kinase inhibitor protein and cancer stem
cell transcription factors (Oct4, KLF4, Sox2, Nanog). Tumour Biol.
39:1010428317692252017. View Article : Google Scholar
|
|
31
|
Wu H, Chen L, Zhu F, Han X, Sun L and Chen
K: The cytotoxicity effect of resveratrol: Cell cycle arrest and
induced apoptosis of breast cancer 4T1 cells. Toxins (Basel).
11:7312019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fukuda M, Ogasawara Y, Hayashi H, Inoue K
and Sakashita H: Resveratrol inhibits proliferation and induces
autophagy by blocking SREBP1 expression in oral cancer cells.
Molecules. 27:82502022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Liu Z, Zhang L, Yang Z, Chen X,
Luo J, Zhou Z, Mei X, Yu X, Shao Z, et al: Targeting deubiquitinase
USP28 for cancer therapy. Cell Death Dis. 9:1862018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao L, Zhang T, Feng X, Chang J, Suo FZ,
Ma JL, Liu YJ, Liu Y, Zheng YC and Liu HM: USP28 contributes to the
proliferation and metastasis of gastric cancer. J Cell Biochem.
120:7657–7666. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maier CR, Hartmann O, Prieto-Garcia C,
Al-Shami KM, Schlicker L, Vogel FCE, Haid S, Klann K, Buck V, Münch
C, et al: USP28 controls SREBP2 and the mevalonate pathway to drive
tumour growth in squamous cancer. Cell Death Differ. 30:1710–1725.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Xu Z, Li Q, Feng Q, Zheng C, Du Y,
Yuan R and Peng X: USP28 facilitates pancreatic cancer progression
through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Cell Death Dis. 12:8872021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prieto-Garcia C, Tomašković I, Shah VJ,
Dikic I and Diefenbacher M: USP28: Oncogene or tumor suppressor? A
unifying paradigm for squamous cell carcinoma. Cells. 10:26522021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Serra RW, Fang M, Park SM, Hutchinson L
and Green MR: A KRAS-directed transcriptional silencing pathway
that mediates the CpG island methylator phenotype. Elife.
3:e023132014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diefenbacher ME, Popov N, Blake SM,
Schülein-Völk C, Nye E, Spencer-Dene B, Jaenicke LA, Eilers M and
Behrens A: The deubiquitinase USP28 controls intestinal homeostasis
and promotes colorectal cancer. J Clin Invest. 124:3407–3418. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faid I, Al-Hussaini H and Kilarkaje N:
Resveratrol alleviates diabetes-induced testicular dysfunction by
inhibiting oxidative stress and c-Jun N-terminal kinase signaling
in rats. Toxicol Appl Pharmacol. 289:482–494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang M, Jiang S, Yu F, Zhou L and Wang K:
Noncoding RNAs as molecular targets of resveratrol underlying its
anticancer effects. J Agric Food Chem. 67:4709–4719. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fouad M, Agha A, Merzabani MA and Shouman
S: Resveratrol inhibits proliferation, angiogenesis and induces
apoptosis in colon cancer cells: Calorie restriction is the force
to the cytotoxicity. Hum Exp Toxicol. 32:1067–1080. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hao X, Ma C, Chen S, Dang J, Cheng X and
Zhu D: Reverse the down regulation of miR-92b-3p by hypoxia can
suppress the proliferation of pulmonary artery smooth muscle cells
by targeting USP28. Biochem Biophys Res Commun. 503:3064–3077.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang JF: MicroRNA-216b suppresses the
cell growth of hepatocellular carcinoma by inhibiting
Ubiquitin-specific peptidase 28 expression. Kaohsiung J Med Sci.
36:423–428. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saei A, Palafox M, Benoukraf T, Kumari N,
Jaynes PW, Iyengar PV, Muñoz-Couselo E, Nuciforo P, Cortés J,
Nötzel C, et al: Loss of USP28-mediated BRAF degradation drives
resistance to RAF cancer therapies. J Exp Med. 215:1913–1928. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu X, Chen M, Li L, Gong L, Zhou H and
Gao D: Extracellular signal-regulated kinases (ERKs) phosphorylate
lin28a protein to modulate P19 cell proliferation and
differentiation. J Biol Chem. 292:3970–3976. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Polesskaya A, Cuvellier S, Naguibneva I,
Duquet A, Moss EG and Harel-Bellan A: Lin-28 binds IGF-2 mRNA and
participates in skeletal myogenesis by increasing translation
efficiency. Genes Dev. 21:1125–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wilbert ML, Huelga SC, Kapeli K, Stark TJ,
Liang TY, Chen SX, Yan BY, Nathanson JL, Hutt KR, Lovci MT, et al:
LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing
factor abundance. Mol Cell. 48:195–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Närvä E, Rahkonen N, Emani MR, Lund R,
Pursiheimo JP, Nästi J, Autio R, Rasool O, Denessiouk K, Lähdesmäki
H, et al: RNA-binding protein L1TD1 interacts with LIN28 via RNA
and is required for human embryonic stem cell self-renewal and
cancer cell proliferation. Stem Cells. 30:452–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jin J, Jing W, Lei XX, Feng C, Peng S,
Boris-Lawrie K and Huang Y: Evidence that Lin28 stimulates
translation by recruiting RNA helicase A to polysomes. Nucleic
Acids Res. 39:3724–3734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kortam MA, Ali BM and Fathy N: The
deleterious effect of stress-induced depression on rat liver:
Protective role of resveratrol and dimethyl fumarate via inhibiting
the MAPK/ERK/JNK pathway. J Biochem Mol Toxicol. 35:e226272021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu X, Sun Z, Nie S, Zhang T and Lu H:
Effects of resveratrol on mouse B16 melanoma cell proliferation
through the SHCBP1-ERK1/2 signaling pathway. Molecules.
28:76142023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu S, Ren J, Liu S, Zhao X, Liu H, Zhou
T, Wang X, Liu H, Tang L and Chen H: Resveratrol inhibits autophagy
against myocardial ischemia-reperfusion injury through the
DJ-1/MEKK1/JNK pathway. Eur J Pharmacol. 951:1757482023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tan T, Gao B, Yu H, Pan H, Sun Z, Lei A,
Zhang L, Lu H, Wu H, Daley GQ, et al: Dynamic nucleolar phase
separation influenced by non-canonical function of LIN28A instructs
pluripotent stem cell fate decisions. Nat Commun. 15:12562024.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Moon HJ, Lee NY, Do EK, Lee SY, Park GT,
Lim JK, Seo JK and Kim JH: Kap1 regulates the stability of Lin28A
in embryonic stem cells. Stem Cells. 40:385–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH,
Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28
reciprocal negative regulatory circuit promotes breast cancer stem
cell maintenance. Cell Death Dis. 8:e2569. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ren X, Jiang M, Ding P, Zhang X, Zhou X,
Shen J, Liu D, Yan X and Ma Z: Ubiquitin-specific protease 28: The
decipherment of its dual roles in cancer development. Exp Hematol
Oncol. 12:272023. View Article : Google Scholar : PubMed/NCBI
|
